Hisashi Tanaka

15PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsFood properties (incl. characteristics and health benefits)Nanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 11, 2026
Efficacy of ipilimumab plus nivolumab with or without chemotherapy according to baseline tumor size: a multicenter retrospective study.

|Nov 28, 2023
Extended ICI treatment after first-line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non-small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study).

Ou Yamaguchi, Keita Mori, Saori Takata

|Nov 21, 2022
Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first-line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021-01).

Shinya Uematsu, Satoru Kitazono, Hisashi Tanaka

|Aug 18, 2022
A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630.

Yuri Taniguchi, Tsuneo Shimokawa, Yuichi Takiguchi

|Apr 13, 2022
Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non-small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020-02).

Hisashi Tanaka, Hiroaki Sakamoto, Takahiro Akita

|Feb 15, 2022
Diabetic ketoacidosis shortly after COVID-19 vaccination in a non-small-cell lung cancer patient receiving combination of PD-1 and CTLA-4 inhibitors: A case report.

Tomonori Makiguchi, Takashi Fukushima, Hisashi Tanaka

Pageof 3

Frequent Collaborators

2 joint publications

Tomonori Makiguchi

2 joint publications

Makoto Nishio

1 joint publications

Chiori Tabe

1 joint publications

Yoshihito Tanaka